Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine

Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.22 -0.12 (1.16%)
Previous Close $10.34    52 Week High $9.23 
Open $10.50    52 Week Low $1.16 
Day High $10.75    P/E N/A 
Day Low $10.05    EPS $-0.30 
Volume 5,125,029       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.22 -0.12 (1.16%)
Previous Close $10.34    52 Week High $9.23 
Open $10.50    52 Week Low $1.16 
Day High $10.75    P/E N/A 
Day Low $10.05    EPS $-0.30 
Volume 5,125,029